Clinical Focus
Previous Articles Next Articles
Online:
Published:
Contact:
Abstract: ObjectiveTo investigate the medication in patients with bronchial asthma, so as to understand the current status of treatment in bronchial asthma patients in Rizhao city. MethodsA total of 229 patients were selected in a face to face questionnaire survey. The disease identification, history and medication including the kinds, dosage form and time of medication were surveyed. ResultsThe percentages of 229 patients with theophylline and shortacting beta2 receptor agonists (included oral and inhale types) were 78.6% and 68.1%, respectively; The percentage with inhaled corticosteroids(ICS) was 44.5%; The percentage with nonconformal drugs was 36.2%; The average time in patients with oral hormone was longer than that of ICS(P<0.01); There was statistical significance in age and disease course between nonconformal and conformal drugs (P<0.05).ConclusionIn Rizhao city, the medication in patients with bronchial asthma was not reasonable; the drugs of theophylline and shortacting beta2 receptor agonists in bronchial asthma were prior to the drugs of ICS. There was still a certain proportion of patients with oral hormone, but patients with nonconformal drugs were older and their disease courses were longer than those with conformal drugs.
Key words: asthma, theophylline, adrenergic beta2 receptor agonists;glucocorticoids
Feng Liancai, Wang Li. Medication in patients with bronchial asthma in Rizhao city[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2017.05.016.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2017.05.016
https://huicui.hebmu.edu.cn/EN/Y2017/V32/I5/441